Добро пожаловать в клуб

Показать / Спрятать  Домой  Новости Статьи Файлы Форум Web ссылки F.A.Q. Логобург    Показать / Спрятать

Главное меню
ДомойНовостиСтатьиДефектологияПостановка звуковФайлыКнижный мирФорумСловарьРассылкаКаталог ссылокРейтинг пользователейЧаВо(FAQ)КонкурсWeb магазинШкольникамЭлектроникаБыт.техникаКарта сайта

Поздравляем нового Логобуржца Dorofeeva со вступлением в клуб!



Drug-resistant tuberculosis therapy: adverse events and risk factors   Evans Sagwa

Drug-resistant tuberculosis therapy: adverse events and risk factors

164 страниц. 2013 год.
LAP Lambert Academic Publishing
The world is seeing unprecedented numbers of people infected with drug-resistant tuberculosis(DR-TB) in patients who have previously failed tuberculosis (TB) treatment and also in patients newly diagnosed with TB. “Left untreated, the infectious disease is lethal, but treatment today puts people through two years of excruciating side effects, including psychosis, deafness and constant nausea, with painful daily injections for up to eight months. Barely half of people get cured” – Press release by Medecins Sans Frontieres - Access Campaign, March 19, 2013 (msfaccess.org/TBmanifesto). The advent and spread of DR-TB posses a great challenge in the treatment of TB, especially among patients also infected with the Human Immunodeficiency Virus (HIV). Namibia is an example of a country that is currently coping with a dual burden of HIV and HIV-associated TB. In 2009, 58% of all TB patients were HIV co-infected and 372 cases of DR-TB were reported. This research work, therefore, provides...
- Генерация страницы: 0.04 секунд -